본문 바로가기
KERD
논문KCI 등재

Prevalence of Cerebral Amyloid Angiopathy Pathology and Strictly Lobar Microbleeds in East-Asian Versus Western Populations: A Systematic Review and Meta-Analysis

Anna M. De Kort|Marcel M. Verbeek|Floris H.B.M. Schreuder|Catharina J.M. Klijn|Lieke Jäkel
대한뇌졸중학회 (The Korean Stroke Society)|2024.05|대한뇌졸중영문학회지 (Journal of stroke)|제26권 제2호|pp. 179-189

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

AsiaEuropeEpidemiologyPrevalenceCerebral amyloid angiopathyMicrobleeds
주제분류신경과학

초록

Background and Purpose Possible differences in the prevalence of cerebral amyloid angiopathy (CAA) in East-Asian compared to Western populations have received little attention, and results so far have been ambiguous. Our aim is to compare the prevalence of CAA neuropathology and magnetic resonance imaging markers of CAA in East-Asian and Western cohorts reflecting the general population, cognitively normal elderly, patients with Alzheimer’s disease (AD), and patients with (lobar) intracerebral hemorrhage (ICH). Methods We performed a systematic literature search in PubMed and Embase for original research papers on the prevalence of CAA and imaging markers of CAA published up until February 17th 2022. Records were screened by two independent reviewers. Pooled estimates were determined using random-effects models. We compared studies from Japan, China, Taiwan, South Korea (East- Asian cohorts) to studies from Europe or North America (Western cohorts) by meta-regression models. Results We identified 12,257 unique records, and we included 143 studies on Western study populations and 53 studies on East-Asian study populations. Prevalence of CAA neuropathology did not differ between East-Asian and Western cohorts in any of the investigated patient domains. The prevalence of strictly lobar microbleeds was lower in East-Asian cohorts of population-based individuals (5.6% vs. 11.4%, P=0.020), cognitively normal elderly (2.6% vs. 11.4%, P=0.001), and patients with ICH (10.2% vs. 24.6%, P<0.0001). However, age was in general lower in the East- Asian cohorts. Conclusion The prevalence of CAA neuropathology in the general population, cognitively normal elderly, patients with AD, and patients with (lobar) ICH is similar in East-Asian and Western countries. In East-Asian cohorts reflecting the general population, cognitively normal elderly, and patients with ICH, strictly lobar microbleeds were less prevalent, likely due to their younger age. Consideration of potential presence of CAA is warranted in decisions regarding antithrombotic treatment and potential new anti-amyloid-β immunotherapy as treatment for AD in East-Asian and Western countries alike.

Abstract

Background and Purpose Possible differences in the prevalence of cerebral amyloid angiopathy (CAA) in East-Asian compared to Western populations have received little attention, and results so far have been ambiguous. Our aim is to compare the prevalence of CAA neuropathology and magnetic resonance imaging markers of CAA in East-Asian and Western cohorts reflecting the general population, cognitively normal elderly, patients with Alzheimer’s disease (AD), and patients with (lobar) intracerebral hemorrhage (ICH). Methods We performed a systematic literature search in PubMed and Embase for original research papers on the prevalence of CAA and imaging markers of CAA published up until February 17th 2022. Records were screened by two independent reviewers. Pooled estimates were determined using random-effects models. We compared studies from Japan, China, Taiwan, South Korea (East- Asian cohorts) to studies from Europe or North America (Western cohorts) by meta-regression models. Results We identified 12,257 unique records, and we included 143 studies on Western study populations and 53 studies on East-Asian study populations. Prevalence of CAA neuropathology did not differ between East-Asian and Western cohorts in any of the investigated patient domains. The prevalence of strictly lobar microbleeds was lower in East-Asian cohorts of population-based individuals (5.6% vs. 11.4%, P=0.020), cognitively normal elderly (2.6% vs. 11.4%, P=0.001), and patients with ICH (10.2% vs. 24.6%, P<0.0001). However, age was in general lower in the East- Asian cohorts. Conclusion The prevalence of CAA neuropathology in the general population, cognitively normal elderly, patients with AD, and patients with (lobar) ICH is similar in East-Asian and Western countries. In East-Asian cohorts reflecting the general population, cognitively normal elderly, and patients with ICH, strictly lobar microbleeds were less prevalent, likely due to their younger age. Consideration of potential presence of CAA is warranted in decisions regarding antithrombotic treatment and potential new anti-amyloid-β immunotherapy as treatment for AD in East-Asian and Western countries alike.

참고문헌 (196)

  1. Alafuzoff I, "Mixed brain pathology is the most common cause of cognitive impairment in the elderly", J Alzheimers Dis, 78, pp.453~465 (2020)
  2. Alafuzoff I, "β-amyloid deposition in brains of subjects with diabetes", Neuropathol Appl Neurobiol, 35, pp.60~68 (2009)
  3. Attems J, "Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy : an autopsy study", J Neurol, 255, pp.70~76 (2008)
  4. Cholerton B, "Neuropathologic correlates of cognition in a population-based sample", J Alzheimers Dis, 36, pp.699~709 (2013)
  5. Conner SC, "Mid-life and late-life vascular risk factor burden and neuropathology in old age", Ann Clin Transl Neurol, 6, pp.2403~2412 (2019)
  6. Erten-Lyons D, "Neuropathologic basis of age-associated brain atrophy", JAMA Neurol, 70, pp.616~622 (2013)
  7. Hamasaki H, "Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults : the Hisayama study", Brain Pathol, 32, pp.e13014~ (2022)
  8. Hamilton CA, "Neurodegenerative brain changes are associated with area deprivation in the United Kingdom : findings from the brains for dementia research study", Acta Neuropathol Commun, 9, pp.198~ (2021)
  9. Itoh Y, "Subpial βA4 peptide deposits are closely associated with amyloid angiopathy in the elderly", Neurosci Lett, 155, pp.144~147 (1993)
  10. Karanth SD, "Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology", Brain, 145, pp.2518~2527 (2022)
  11. Kovacs GG, "Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain : a community-based autopsy series", Acta Neuropathol, 126, pp.365~384 (2013)
  12. Kövari E, "The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer’s disease", Neuropathol Appl Neurobiol, 39, pp.498~509 (2013)
  13. Kövari E, "No neuropathological evidence for a direct topographical relation between microbleeds and cerebral amyloid angiopathy", Acta Neuropathol Commun, 3, pp.49~ (2015)
  14. Masuda J, "Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan", Stroke, 19, pp.205~210 (1988)
  15. Matthews FE, "Epidemiological pathology of dementia : attributable-risks at death in the Medical Research Council cognitive function and ageing study", PLoS Med, 6, pp.e1000180~ (2009)
  16. Moghekar A, "Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort", Alzheimers Dement, 8(5 Suppl), pp.S71~S77 (2012)
  17. Ng TH, "Cerebral amyloid angiopathy in Chinese : incidence and significance", Clin Neurol Neurosurg, 93, pp.19~23 (1991)
  18. Oveisgharan S, "Sex differences in Alzheimer’s disease and common neuropathologies of aging", Acta Neuropathol, 136, pp.887~900 (2018)
  19. Robinson JL, "Non-Alzheimer’s contributions to dementia and cognitive resilience in the 90+ study", Acta Neuropathol, 136, pp.377~388 (2018)
  20. Robinson AC, "Pathological correlates of cognitive impairment in the University of Manchester longitudinal study of cognition in normal healthy old age", J Alzheimers Dis, 64, pp.483~496 (2018)
  21. Tanprasertsuk J, "Clinico-neuropathological findings in the oldest old from the Georgia centenarian study", J Alzheimers Dis, 70, pp.35~49 (2019)
  22. Tanskanen M, "Prevalence and severity of cerebral amyloid angiopathy : a population-based study on very elderly Finns(Vantaa 85+)", Neuropathol Appl Neurobiol, 38, pp.329~336 (2012)
  23. Vinters HV, "Cerebral amyloid angiopathy : incidence and complications in the aging brain. II. The distribution of amyloid vascular changes", Stroke, 14, pp.924~928 (1983)
  24. Vonsattel JP, "Cerebral amyloid angiopathy without and with cerebral hemorrhages : a comparative histological study", Ann Neurol, 30, pp.637~649 (1991)
  25. Xu D, "Cerebral amyloid angiopathy in aged Chinese : a clinico-neuropathological study", Acta Neuropathol, 106, pp.89~91 (2003)
  26. Alakbarzade V, "Cerebral amyloid angiopathy distribution in older people : a cautionary note", Alzheimers Dement(N Y), 7, pp.e12145~ (2021)
  27. Bergeron C, "Amyloid angiopathy in Alzheimer’s disease", Can J Neurol Sci, 14, pp.564~569 (1987)
  28. Bertrand E, "Amyloid angiopathy in idiopathic Parkinson’s disease. Immunohistochemical and ultrastructural study", Folia Neuropathol, 46, pp.255~270 (2008)
  29. Brayne C, "Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort(CC75C)study", J Alzheimers Dis, 18, pp.645~658 (2009)
  30. Chalmers K, "APOEɛ4 influences the pathological phenotype of Alzheimer’s disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein", Neuropathol Appl Neurobiol, 29, pp.231~238 (2003)
  31. Cruz-Sánchez FF, "Correlation between Apolipoprotein-E polymorphism and Alzheimer’s disease pathology", J Alzheimers Dis, 2, pp.223~229 (2000)
  32. Dallaire-Théroux C, "Histopathological analysis of cerebrovascular lesions associated with aging", J Neuropathol Exp Neurol, 81, pp.97~105 (2022)
  33. Davis DG, "Alzheimer neuropathologic alterations in aged cognitively normal subjects", J Neuropathol Exp Neurol, 58, pp.376~388 (1999)
  34. De Reuck J, "Prevalence of cerebrovascular lesions in patients with Lewy body dementia : a neuropathological study", Clin Neurol Neurosurg, 115, pp.1094~1097 (2013)
  35. De Reuck J, "The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes : a neuropathological study", Neurol Res Int, 2019, pp.7247325~ (2019)
  36. Dickson DW, "Identification of normal and pathological aging in prospectively studied nondemented elderly humans", Neurobiol Aging, 13, pp.179~189 (1992)
  37. Dugger BN, "Concomitant pathologies among a spectrum of parkinsonian disorders", Parkinsonism Relat Disord, 20, pp.525~529 (2014)
  38. Esiri M, "Cerebral amyloid angiopathy, subcortical white matter disease and dementia : literature review and study in OPTIMA", Brain Pathol, 25, pp.51~62 (2015)
  39. Esiri MM, "Cerebral amyloid angiopathy in dementia and old age", J Neurol Neurosurg Psychiatry, 49, pp.1221~1226 (1986)
  40. Guidoux C, "Amyloid angiopathy in brain hemorrhage : a postmortem neuropathological-magnetic resonance imaging study", Cerebrovasc Dis, 45, pp.124~131 (2018)
  41. Haglund M, "Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy-a histopathological assessment", Dement Geriatr Cogn Disord, 14, pp.161~166 (2002)
  42. Head E, "Cerebrovascular pathology in Down syndrome and Alzheimer disease", Acta Neuropathol Commun, 5, pp.93~ (2017)
  43. Honig LS, "Atherosclerosis and AD : analysis of data from the US National Alzheimer’s Coordinating Center", Neurology, 64, pp.494~500 (2005)
  44. Jellinger KA, "Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases", Neurodegener Dis, 7, pp.112~115 (2010)
  45. Kawas CH, "Multiple pathologies are common and related to dementia in the oldest-old : the 90+ study", Neurology, 85, pp.535~542 (2015)
  46. Love S, "APOE and cerebral amyloid angiopathy in the elderly", Neuroreport, 14, pp.1535~1536 (2003)
  47. Magaki S, "Comorbidity in dementia : update of an ongoing autopsy study", J Am Geriatr Soc, 62, pp.1722~1728 (2014)
  48. Malek-Ahmadi M, "Cerebral amyloid angiopathy and neuritic plaque pathology correlate with cognitive decline in elderly non-demented individuals", J Alzheimers Dis, 67, pp.411~422 (2019)
  49. McAleese KE, "Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains : implications for fibrinogen as a biomarker for Alzheimer’s disease", Brain Pathol, 29, pp.414~424 (2019)
  50. McKee AC, "Visual association pathology in preclinical Alzheimer disease", J Neuropathol Exp Neurol, 65, pp.621~630 (2006)
  51. Mountjoy CQ, "Amyloid and senile plaques and cerebral blood vessels. A semi-quantitative investigation of a possible relationship", J Neurol Sci, 57, pp.89~103 (1982)
  52. Premkumar DR, "Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease", Am J Pathol, 148, pp.2083~2095 (1996)
  53. Shim YS, "Pathological correlates of white matter hyperintensities on magnetic resonance imaging", Dement Geriatr Cogn Disord, 39, pp.92~104 (2015)
  54. Sugarman MA, "Failure to detect an association between selfreported traumatic brain injury and Alzheimer’s disease neuropathology and dementia", Alzheimers Dement, 15, pp.686~698 (2019)
  55. Wu E, "Amyloid angiopathy in diffuse Lewy body disease", Neurology, 42, pp.2131~2135 (1992)
  56. Xu Dan, "Histomorphological features of brain aging: different types of cerebral amyloid angiopathy and beta-amyloid protein disposition in brain parenchyma", Chinese J Clin Rehabil, 8, pp.6885~6887 (2004)
  57. Yamada M, "Risk factors for cerebral amyloid angiopathy in the elderly", Ann N Y Acad Sci, 977, pp.37~44 (2002)
  58. Bell MA, "Neuritic plaques and vessels of visual cortex in aging and Alzheimer’s dementia", Neurobiol Aging, 11, pp.359~370 (1990)
  59. Boon BDC, "The coarse-grained plaque : a divergent Aβplaque-type in early-onset Alzheimer’s disease", Acta Neuropathol, 140, pp.811~830 (2020)
  60. Boyle PA, "Attributable risk of Alzheimer’s dementia attributed to age-related neuropathologies", Ann Neurol, 85, pp.114~124 (2019)
  61. Chen ZC, "The vascular risk factors and vascular neuropathology in subjects with autopsy-confirmed dementia with Lewy bodies", Int J Geriatr Psychiatry, 37, pp.gps.5683~ (2022)
  62. Del Ser T, "Alzheimer’s disease with and without cerebral infarcts", J Neurol Sci, 231, pp.3~11 (2005)
  63. Dugger BN, "Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates", J Neuropathol Exp Neurol, 73, pp.72~80 (2014)
  64. Ellis RJ, "Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease : the CERAD experience, part XV", Neurology, 46, pp.1592~1596 (1996)
  65. Fallet-Bianco C, "Neuropathologic study of 50 cases of senile dementia", Rev Neurol(Paris), 146, pp.687~696 (1990)
  66. Glenner GG, "Congophilic angiopathy in the pathogenesis of Alzheimer’s degeneration", Ann Pathol, 1, pp.120~129 (1981)
  67. Helman AM, "Microbleeds and cerebral amyloid angiopathy in the brains of people with Down syndrome with Alzheimer’s disease", J Alzheimers Dis, 67, pp.103~112 (2019)
  68. Jellinger K, "Cerebrovascular amyloidosis with cerebral hemorrhage", J Neurol, 214, pp.195~206 (1977)
  69. Jellinger KA, "The impact of cerebrovascular lesions in Alzheimer disease--a comparative autopsy study", J Neurol, 250, pp.1050~1055 (2003)
  70. Jicha GA, "Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia", Arch Neurol, 63, pp.674~681 (2006)
  71. Joachim CL, "Clinically diagnosed Alzheimer’s disease : autopsy results in 150 cases", Ann Neurol, 24, pp.50~56 (1988)
  72. Kurucz J, "Quantitative clinicopathologic study of cerebral amyloid angiopathy", J Am Geriatr Soc, 29, pp.61~69 (1981)
  73. Leech RW, "Dementia : the University of Oklahoma autopsy experience", J Okla State Med Assoc, 94, pp.507~511 (2001)
  74. Liu D, "Pathomorphological and amyloid beta-protein immunohistochemical findings in autopsied brains of Alzheimer’s disease", Zhonghua Bing Li Xue Za Zhi, 28, pp.405~408 (1999)
  75. Lopez OL, "Cerebral amyloid angiopathy in Alzheimer’s disease : clinicopathological correlations", Dementia, 2, pp.285~290 (1991)
  76. Mandybur TI, "The incidence of cerebral amyloid angiopathy in Alzheimer’s disease", Neurology, 25, pp.120~126 (1975)
  77. Mann DMA, "Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease", Acta Neuropathol, 136, pp.569~587 (2018)
  78. Nation DA, "Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer’s disease", J Alzheimers Dis, 30, pp.595~603 (2012)
  79. Olichney JM, "Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4", Arch Neurol, 57, pp.869~874 (2000)
  80. Parker JC Jr, "Postmortem evaluation of Alzheimer’s disease", South Med J, 78, pp.1411~1413 (1985)
  81. Pirttilä T, "Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer’s disease : correlations with amyloid load in the brain", Arch Neurol, 53, pp.189~193 (1996)
  82. Pivtoraiko VN, "Postmortem neocortical 3H-PiB binding and levels of unmodified and pyroglutamate Aβ in Down syndrome and sporadic Alzheimer’s disease", Front Aging Neurosci, 13, pp.728739~ (2021)
  83. Reimand J, "Amyloid-β PET and CSF in an autopsyconfirmed cohort", Ann Clin Transl Neurol, 7, pp.2150~2160 (2020)
  84. Shinohara M, "Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease", Acta Neuropathol, 132, pp.225~234 (2016)
  85. Spina S, "Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease", Brain, 144, pp.2186~2198 (2021)
  86. Tomimoto H, "Vascular changes in white matter lesions of Alzheimer’s disease", Acta Neuropathol, 97, pp.629~634 (1999)
  87. Vik-Mo AO, "Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 90, pp.728~730 (2019)
  88. Yamada M, "Systemic amyloid deposition in old age and dementia of Alzheimer type : the relationship of brain amyloid to other amyloid", Acta Neuropathol, 77, pp.136~141 (1988)
  89. Yip AG, "APOE, vascular pathology, and the AD brain", Neurology, 65, pp.259~265 (2005)
  90. Zarow C, "Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss", Alzheimer Dis Assoc Disord, 13, pp.1~8 (1999)
  91. Dye JA, "Neuropathologic analysis of hematomas evacuated from patients with spontaneous intracerebral hemorrhage", Neuropathology, 34, pp.253~260 (2014)
  92. Fazekas F, "Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage : evidence of microangiopathy-related microbleeds", AJNR Am J Neuroradiol, 20, pp.637~642 (1999)
  93. Holling M, "Histopathological analysis of intracerebral hemorrhage : implications for clinical management", Acta Neurochir(Wien), 154, pp.439~443 (2012)
  94. Ishihara T, "The significance of cerebrovascular amyloid in the aetiology of superficial(lobar)cerebral haemorrhage and its incidence in the elderly population", J Pathol, 165, pp.229~234 (1991)
  95. Lieber AC, "Biopsy during minimally invasive intracerebral hemorrhage clot evacuation", World Neurosurg, 124, pp.e169~e175 (2019)
  96. Mendel TA, "The association between cerebral amyloid angiopathy and atherosclerosis in patients with intracerebral hemorrhages", Folia Neuropathol, 51, pp.243~249 (2013)
  97. Ritter MA, "Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients", Neurology, 64, pp.1233~1237 (2005)
  98. Rodrigues MA, "The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy : model development and diagnostic test accuracy study", Lancet Neurol, 17, pp.232~240 (2018)
  99. Tang YJ, "The incidence of cerebral amyloid angiopathy in surgically treated intracranial hemorrhage in the Chinese population", Neurosurg Rev, 36, pp.533~539 (2013)
  100. Baron JC, "Cerebral amyloid angiopathy-related acute lobar intra-cerebral hemorrhage : diagnostic value of plain CT", J Neurol, 269, pp.2126~2132 (2022)
  101. Doden T, "Clinico-radiological characteristics and pathological diagnosis of cerebral amyloid angiopathy-related intracerebral hemorrhage", J Stroke Cerebrovasc Dis, 25, pp.1736~1745 (2016)
  102. Itoh Y, "Cerebral amyloid angiopathy : a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly", J Neurol Sci, 116, pp.135~141 (1993)
  103. Knudsen KA, "Clinical diagnosis of cerebral amyloid angiopathy : validation of the Boston criteria", Neurology, 56, pp.537~539 (2001)
  104. Lin CM, "Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages", J Neurol, 265, pp.567~577 (2018)
  105. Minakawa T, "Surgical experience with massive lobar haemorrhage caused by cerebral amyloid angiopathy", Acta Neurochir(Wien), 132, pp.48~52 (1995)
  106. Yoshimura M, "Dementia in cerebral amyloid angiopathy : a clinicopathological study", J Neurol, 239, pp.441~450 (1992)
  107. Aarts N, "Inhibition of serotonin reuptake by antidepressants and cerebral microbleeds in the general population", Stroke, 45, pp.1951~1957 (2014)
  108. Chung CP, "Cerebral microbleeds are associated with physical frailty : a community-based study", Neurobiol Aging, 44, pp.143~150 (2016)
  109. Elmståhl S, "Association between cerebral microbleeds and hypertension in the Swedish general population"Good Aging in Skåne"study", J Clin Hypertens(Greenwich), 21, pp.1099~1107 (2019)
  110. Graff-Radford J, "Cerebral microbleeds : relationship to antithrombotic medications", Stroke, 52, pp.2347~2355 (2021)
  111. Han F, "Prevalence and risk factors of cerebral small vessel disease in a Chinese population-based sample", J Stroke, 20, pp.239~246 (2018)
  112. Kim CK, "No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly", J Neurol Sci, 319, pp.56~58 (2012)
  113. Miwa K, "Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors", Neurology, 83, pp.646~653 (2014)
  114. Paganini-Hill A, "Blood pressure circadian variation, cognition and brain imaging in 90+ year-olds", Front Aging Neurosci, 11, pp.54~ (2019)
  115. Qiu C, "Cerebral microbleeds and age-related macular degeneration : the AGES-Reykjavik study", Neurobiol Aging, 33, pp.2935~2937 (2012)
  116. Romero JR, "Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham heart study", Stroke, 45, pp.1492~1494 (2014)
  117. Tsushima Y, "Brain microhemorrhages detected on T2*-weighted gradient-echo MR images", AJNR Am J Neuroradiol, 24, pp.88~96 (2003)
  118. Wang Y, "Deep", mixed cerebral microbleeds are associated with cognitive dysfunction through thalamocortical connectivity disruption : the Taizhou imaging study, 2019, pp.22, 101749~
  119. Ying YQ, "The analysis of association between imaging biomarkers of cerebral small vessel disease and cognitive impairment: a Shanghai elderly community-based cohort", Chinese J Contemp Neurol Neurosurg, 21, pp.843~852 (2021)
  120. Yubi T, "Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community", Neurol Clin Pract, 8, pp.223~231 (2018)
  121. Atri A, "Prevalence and effects of lobar microhemorrhages in early-stage dementia", Neurodegener Dis, 2, pp.305~312 (2005)
  122. Barnaure I, "Clinicoradiologic correlations of cerebral microbleeds in advanced age", AJNR Am J Neuroradiol, 38, pp.39~45 (2017)
  123. Brundel M, "Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes", Diabetes, 63, pp.3523~3529 (2014)
  124. Chang Y, "Diagnostic utility of integrated 11C-Pittsburgh compound B positron emission tomography", magnetic resonance for cerebral amyloid angiopathy : a pilot study, 2021, pp.13, 721780~
  125. Chiang GC, "Cerebral microbleeds, CSF p-Tau, and cognitive decline : significance of anatomic distribution", AJNR Am J Neuroradiol, 36, pp.1635~1641 (2015)
  126. Donaghy PC, "Microbleeds in dementia with Lewy bodies", J Neurol, 267, pp.1491~1498 (2020)
  127. Graff-Radford J, "Neuroimaging correlates of cerebral microbleeds : the ARIC study(Atherosclerosis Risk in Communities)", Stroke, 48, pp.2964~2972 (2017)
  128. Gregg NM, "Incidental cerebral microbleeds and cerebral blood flow in elderly individuals", JAMA Neurol, 72, pp.1021~1028 (2015)
  129. Ham JH, "Cerebral microbleeds in patients with Parkinson’s disease", J Neurol, 261, pp.1628~1635 (2014)
  130. Johansson E, "Cerebral microbleeds in idiopathic normal pressure hydrocephalus", Fluids Barriers CNS, 13, pp.4~ (2016)
  131. Kwon HM, "Visceral fat is an independent predictor of cerebral microbleeds in neurologically healthy people", Cerebrovasc Dis, 42, pp.90~96 (2016)
  132. Mendes A, "Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias", Neurology, 90, pp.e1057~e1065 (2018)
  133. Mitaki S, "Serum lipid fractions and cerebral microbleeds in a healthy Japanese population", Cerebrovasc Dis, 43, pp.186~191 (2017)
  134. Nakata-Kudo Y, "Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease", Dement Geriatr Cogn Disord, 22, pp.8~14 (2006)
  135. Ochi N, "Silent cerebral microbleeds associated with arterial stiffness in an apparently healthy subject", Hypertens Res, 32, pp.255~260 (2009)
  136. Romero JR, "Relation of plasma β-amyloid, clusterin, and tau with cerebral microbleeds : Framingham heart study", Ann Clin Transl Neurol, 7, pp.1083~1091 (2020)
  137. Roob G, "MRI evidence of past cerebral microbleeds in a healthy elderly population", Neurology, 52, pp.991~994 (1999)
  138. Wang PN, "Strictly lobar cerebral microbleeds are associated with increased white matter volume", Transl Stroke Res, 11, pp.29~38 (2020)
  139. Wollenweber FA, "Cortical superficial siderosis in different types of cerebral small vessel disease", Stroke, 48, pp.1404~1407 (2017)
  140. Yakushiji Y, "Basal ganglia cerebral microbleeds and global cognitive function : the Kashima scan study", J Stroke Cerebrovasc Dis, 24, pp.431~439 (2015)
  141. Yilmaz P, "Application of an imaging-based sum score for cerebral amyloid angiopathy to the general population : risk of major neurological diseases and mortality", Front Neurol, 10, pp.1276~ (2019)
  142. Zhang J, "Cerebral microbleeds are associated with mild cognitive impairment in patients with hypertension", J Am Heart Assoc, 7, pp.e008453~ (2018)
  143. Benedictus MR, "Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer’s disease", Neurobiol Aging, 34, pp.2488~2494 (2013)
  144. Boyano I, "Cerebral microbleeds in advanced dementia : clinical and pathological correlates", Am J Alzheimers Dis Other Demen, 33, pp.362~372 (2018)
  145. Charidimou A, "Cortical superficial siderosis in memory clinic patients : further evidence for underlying cerebral amyloid angiopathy", Cerebrovasc Dis, 41, pp.156~162 (2016)
  146. Chiu WT, "Deep cerebral microbleeds are associated with poor cholinesterase inhibitor treatment response in people with Alzheimer disease", Clin Neurol Neurosurg, 195, pp.105959~ (2020)
  147. De Kort AM, "Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer’s disease", Alzheimers Dement, 18, pp.1788~1796 (2022)
  148. Ikeda M, "Cerebral microbleeds, cerebrospinal fluid, and neuroimaging markers in clinical subtypes of Alzheimer’s disease", Front Neurol, 12, pp.543866~ (2021)
  149. Inoue Y, "Diagnostic significance of cortical superficial siderosis for Alzheimer disease in patients with cognitive impairment", AJNR Am J Neuroradiol, 37, pp.223~227 (2016)
  150. Kuroda T, "Increased presence of cerebral microbleeds correlates with ventricular enlargement and increased white matter hyperintensities in Alzheimer’s disease", Front Aging Neurosci, 12, pp.13~ (2020)
  151. Mendes A, "Cortical superficial siderosis : a descriptive analysis in a memory clinic population", J Alzheimers Dis, 73, pp.1467~1479 (2020)
  152. Nagasawa J, "Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleeds", J Stroke Cerebrovasc Dis, 23, pp.2444~2449 (2014)
  153. Noguchi-Shinohara M, "Cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer’s disease", J Alzheimers Dis, 55, pp.905~913 (2017)
  154. Shams S, "Cortical superficial siderosis : prevalence and biomarker profile in a memory clinic population", Neurology, 87, pp.1110~1117 (2016)
  155. Sparacia G, "Assessment of cerebral microbleeds by susceptibility-weighted imaging in Alzheimer’s disease patients : a neuroimaging biomarker of the disease", Neuroradiol J, 30, pp.330~335 (2017)
  156. van der Vlies AE, "Microbleeds do not affect rate of cognitive decline in Alzheimer disease", Neurology, 79, pp.763~769 (2012)
  157. Zhang JB, "Association of serum vascular endothelial growth factor levels and cerebral microbleeds in patients with Alzheimer’s disease", Eur J Neurol, 23, pp.1337~1342 (2016)
  158. Biffi A, "Delayed seizures after intracerebral haemorrhage", Brain, 139(Pt 10), pp.2694~2705 (2016)
  159. Ghelmez D, "Cerebral microbleeds(CMBs)-relevance for mechanisms of cerebral hemorrhage--analysis of 24 MRI evaluated patients", J Med Life, 6, pp.437~439 (2013)
  160. Haussen DC, "Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage", Stroke, 43, pp.2677~2681 (2012)
  161. Jolink WM, "Contrast leakage distant from the hematoma in patients with spontaneous ICH : a 7 T MRI study", J Cereb Blood Flow Metab, 40, pp.1002~1011 (2020)
  162. Laible M, "Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage", J Neurol, 262, pp.2312~2322 (2015)
  163. Martí-Fàbregas J, "Microbleed burden and hematoma expansion in acute intracerebral hemorrhage", Eur Neurol, 70, pp.175~178 (2013)
  164. Schwarz G, "Magnetic resonance imaging-based scores of small vessel diseases : associations with intracerebral haemorrhage location", J Neurol Sci, 434, pp.120165~ (2022)
  165. Tsai HH, "Correlation of cerebral microbleed distribution to amyloid burden in patients with primary intracerebral hemorrhage", Sci Rep, 7, pp.44715~ (2017)
  166. Wang X, "Enlarged perivascular spaces and cerebral small vessel disease in spontaneous intracerebral hemorrhage patients", Front Neurol, 10, pp.881~ (2019)
  167. Xu M, "Total burden of cerebral small vessel disease in recurrent ICH versus first-ever ICH", Aging Dis, 10, pp.570~577 (2019)
  168. Schwarz G, "MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage", Int J Stroke, 18, pp.85~94 (2023)
  169. Pichler M, "Prevalence and natural history of superficial siderosis : a population-based study", Stroke, 48, pp.3210~3214 (2017)
  170. Shoamanesh A, "Cerebral microbleeds and the effect of intensive blood pressure reduction on hematoma expansion and functional outcomes : a secondary analysis of the ATACH-2 randomized clinical trial", JAMA Neurol, 75, pp.850~859 (2018)
  171. Cheng X, "Neurofilament light chain predicts risk of recurrence in cerebral amyloid angiopathy-related intracerebral hemorrhage", Aging(Albany NY), 12, pp.23727~23738 (2020)
  172. Carmona-Iragui M, "Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer’s disease", Alzheimers Dement, 13, pp.1251~1260 (2017)
  173. Na HK, "Cortical superficial siderosis : a marker of vascular amyloid in patients with cognitive impairment", Neurology, 84, pp.849~855 (2015)
  174. Tsai HH, "Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau", Brain, 144, pp.3371~3380 (2021)
  175. Umino M, "Evaluation of cortical superficial siderosis in patients with cognitive dysfunction using 3D FLAIR and 3D DIR", Eur Radiol, 31, pp.6411~6418 (2021)
  176. Zonneveld HI, "Prevalence of cortical superficial siderosis in a memory clinic population", Neurology, 82, pp.698~704 (2014)
  177. Castello JP, "Cerebral small vessel disease and depression among intracerebral hemorrhage survivors", Stroke, 53, pp.523~531 (2022)
  178. Damien C, "Insights in the pathophysiology of haemorrhagic strokes in a sub-Sahara African country, an epidemiological and MRI study", Trop Med Int Health, 26, pp.166~172 (2021)
  179. Moulin S, "Cortical superficial siderosis : a prospective observational cohort study", Neurology, 91, pp.e132~e138 (2018)
  180. Pinho J, "Intracerebral hemorrhage recurrence in patients with and without cerebral amyloid angiopathy", Cerebrovasc Dis Extra, 11, pp.15~21 (2021)
  181. Suda S, "Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke", J Neurol, 264, pp.2413~2419 (2017)
  182. Tsai HH, "Longterm vascular outcomes in patients with mixed location intracerebral hemorrhage and microbleeds", Neurology, 96, pp.e995~e1004 (2021)
  183. Ye X, "Apolipoprotein E genotype predicts subarachnoid extension in spontaneous intracerebral haemorrhage", Eur J Neurol, 28, pp.1992~1999 (2021)
  184. Boulouis G, "Association of key magnetic resonance imaging markers of cerebral small vessel disease with hematoma volume and expansion in patients with lobar and deep intracerebral hemorrhage", JAMA Neurol, 73, pp.1440~1447 (2016)
  185. Renard D, "Subarachnoid extension of lobar hemorrhage on acute", subacute MRI is associated with cerebral amyloid angiopathy criteria, 2020, pp.120, 863~866
  186. Yakushiji Y, "Proportion of intracerebral haemorrhage due to cerebral amyloid angiopathy in the East and West : comparison between single hospital centres in Japan and the United Kingdom", J Neurol Sci, 416, pp.117037~ (2020)
  187. Viguier A, "Subarachnoid and subdural hemorrhages in lobar intracerebral hemorrhage associated with cerebral amyloid angiopathy", Stroke, 50, pp.1567~1569 (2019)
  188. van Rooden S, "Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging", Radiology, 270, pp.205~211 (2014)
  189. Charidimou A, "Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage : a multicentre MRI cohort study", J Neurol Neurosurg Psychiatry, 84, pp.624~629 (2013)
  190. Martí-Fàbregas J, "The HATOMIC criteria for the etiologic classification of patients with intracerebral hemorrhage", PLoS One, 11, pp.e0156992~ (2016)
  191. Pasi M, "Cerebellar microbleed distribution patterns and cerebral amyloid angiopathy", Stroke, 50, pp.1727~1733 (2019)
  192. Pasi M, "Mixed-location cerebral hemorrhage", microbleeds : underlying microangiopathy and recurrence risk, 2018, pp.90, e119~e126
  193. Segal AZ, "Low cholesterol as a risk factor for primary intracerebral hemorrhage : a case-control study", Neuroepidemiology, 18, pp.185~193 (1999)
  194. Tsai HH, "Distribution of lacunar infarcts in Asians with intracerebral hemorrhage : a magnetic resonance imaging and amyloid positron emission tomography study", Stroke, 49, pp.1515~1517 (2018)
  195. Greenberg SM, "Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy", Stroke, 27, pp.1333~1337 (1996)
  196. Jamieson EI, "Dementia is strongly associated with 90-day mortality in lobar cerebral amyloid angiopathy related intracerebral haemorrhage", J Neurol Sci, 322, pp.161~165 (2012)

관련 논문AI추천

Cerebral Amyloid Angiopathy: A Systematic ReviewAlessandro Biffi, Steven M. Greenberg대한신경과학회 · Journal of Clinical Neurology2011 · 제7권 제1호Cerebral Amyloid Angiopathy: An Undeniable Small Vessel DiseaseDongqi Yue, Jun Liu, Li-Tao Wang, Qiong Liu, Yi Fu대한뇌졸중학회 · 대한뇌졸중영문학회지2024 · 제26권 제1호Pathologically Confirmed Cerebral Amyloid Angiopathy with No Radiological Sign in a Patient with Early Onset Alzheimer’s Disease김승주, 김예신, 김희진, 서상원, 서연림, 서유정, Duk L. Na연세대학교의과대학 · Yonsei Medical Journal2018 · 제59권 제6호Cerebral Amyloid Angiopathy: Emerging ConceptsMasahito Yamada대한뇌졸중학회 · 대한뇌졸중영문학회지2015 · 제17권 제1호Coexistence of Cerebral Microbleeds and Amyloid Pathology in Patients with Cognitive Complaints류선영, 심용수, 양동원, 임은예, 조아현대한신경과학회 · Journal of Clinical Neurology2020 · 제16권 제1호Differentiating Cerebral Amyloid Angiopathy From Alzheimer’s Disease Using Dual Amyloid and Tau Positron Emission TomographyAndreas Charidimou, Chia-Ju Liu, Hsin-Hsi Tsai, Jean-Claude Baron, Jiann-Shing Jeng, Li-Kai Tsai, Marco Pasi, Ruoh-Fang Yen, Ya-Chin Tsai, Ya-Fang Chen대한뇌졸중학회 · 대한뇌졸중영문학회지2025 · 제27권 제1호

이 간행물의 다른 논문 (20건)

Leukoaraiosis: Epidemiology, Imaging, Risk Factors, and Management of Age-Related Cerebral White Matter HyperintensitiesQing Lin, Chi-Meng Tzeng, Wen-Qing Huangpp. 131-163Cancer-Associated Stroke: Thrombosis Mechanism, Diagnosis, Outcome, and Therapeutic Strategies남효석, Kwang Hyun Kim, Jaeseob Yun, Jae Wook Jung, Ji Hoe Heo, 유준상, 김영대pp. 164-178Distal Medium Vessel Occlusion Strokes: Understanding the Present and Paving the Way for a Better FutureNirav R. Bhatt, Jin Soo Lee, Mohamed F. Doheim, Raul G. Nogueira, Alhamza R. Al-Bayati, Diogo C. Haussen, Mahmoud Mohammaden, Michael Lang, Matthew Starr, Marcelo Rocha, Catarina Perry da Câmara, Bradley A. Grosspp. 190-202Neuroprotective Approaches for Brain Injury After Cardiac Arrest: Current Trends and Prospective AvenuesXiaofeng Jia, Subash Marasinipp. 203-230The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke RecurrenceZixiao Li, Xia Meng, Anxin Wang, Qin Xu, Xuewei Xie, Jinxi Lin, Xingquan Zhao, Yong Jiang, Yilong Wang, Liping Liu, Yongjun Wang, Hao Li, Jing Jingpp. 231-241
원문 보기